78705641 - PARVULET

Information

  • Trademark
  • 78705641
  • Serial Number
    78705641
  • Registration Number
    4215867
  • Filing Date
    September 01, 2005
    19 years ago
  • Registration Date
    October 02, 2012
    12 years ago
  • Transaction Date
    August 01, 2019
    5 years ago
  • Status Date
    May 03, 2019
    6 years ago
  • Published for Opposition Date
    June 02, 2009
    16 years ago
  • Location Date
    October 02, 2012
    12 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KEARNEY, COLLEEN
  • Attorney Docket Number
    7920244292-U
    Attorney Name
    Dianne M. Lambillotte
    Law Office Assigned Location Code
    M40
  • Owners
Mark Drawing Code
4000
Mark Identification
PARVULET
Case File Statements
  • GS0051: Pharmaceutical and veterinary preparations for the treatment of pain relief and pain management, shock, hemorrhage and bleeding, pre- and post-operative complications in the nature of hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions, respiratory and circulatory crises and dysfunctions, cognitive dysfunctions, fibrosis, infections, fever and sepsis, and traumas and emergencies, namely, fractures, abrasions, burns, psychological and immunological shock, poisons and pollutions, animal bites or stings, fever, respiratory and cardiovascular shock, crises and dysfunctions, and hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions and cognitive dysfunctions, and physical and psychological substance dependence, namely, drug and alcohol dependence, drug tolerance, withdrawal symptoms, convulsions, Alzheimer disease, dementias, Parkinson's disease, insufficient saliva and inability to swallow, allergy/immunology disorders, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases in the nature of flu, AIDS/HIV, anthrax, plague, cholera, biological infections, and prion exposure, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, genitourinary diseases and afflictions, premature labor, poison exposure, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, veterinary preparations for the treatment of bovine, sheep, horses, pigs, poultry, ostrich, rodents, dogs, cats, camels, donkeys, elephants; dietetic food adapted for medical use; diagnostic preparations for medical and veterinary use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; synthetic peptides for pharmaceutical purposes; vitamins; biomedical compounds, namely, peptide substrates for use in analyzing and detecting toxins for medical laboratory use; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets, oral liquids, oral gels, and oral emulsions for the continuous release of a wide variety of therapeutic agents within a certain time after ingestion; medicated candy; medicated chewing gum; breath-freshening chewing gum for medical purposes; medicated lollipops; sweets for medicinal purposes, namely, sweets containing pharmaceutical and medical substances and compounds
  • GS0101: Surgical, medical, dental and veterinary apparatus and instruments, namely, drug delivery apparatus and instruments in the form of containers for various pharmaceuticals, drugs, medicines, compounds and substances in the form of liquids, gels, grains, emulsions, blister packs and sachets; spoons, cups and syringes for administering pharmaceutical substances and medicines; drug delivery systems
  • GS0401: Treatment of materials, namely, milling, mixing, grinding, liquefying, pulverizing, melting and extrusion of medical and pharmaceutical substances, compounds and materials
  • GS0421: Scientific research; technology consultation in the field of scientific research; design for others in the fields of pain relief and pain management, pharmaceutical drug and medicine development, development of medicines and medicine goods and packaging in the fields of traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, occupational diseases and afflictions, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear-nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, veterinary preparations for the treatment of bovine, sheep, horses, pigs, poultry, ostrich, rodents, dogs, cats, camels, donkeys, elephants; chemical, biochemical, biological and bacteriological research and analysis; pharmaceutical drug and medicine development services; design for others in the field of drugs and medicines; development of pharmaceutical preparations and medicines; professional consultancy pertaining to pharmacology, namely, biotechnical and biomedical and medical and pharmaceutical substances, preparations and compounds; professional consultancy in the field of research and development of medicine and the dispensing of pharmaceutical preparations; pharmaceutical drug development services comprised of scientific, industrial, technological, bio technical, pharmaceutical, biomedical and clinical research in the field of drugs and drug candidates; medical and scientific research, namely, conducting clinical trials of new drug candidates; consultation in the field of scientific research pertaining to chemical, pharmaceutical and medical goods; design for others in the field of medical packaging and equipment; development of pharmaceutical preparations and medicines; consultation in the field of biotechnological and biomedical scientific research; biochemical and molecular biological analyses; in vitro and in vivo preclinical tests and clinical tests of drug candidates and potential drugs; consultancy and research regarding pharmaceuticals in gel-like and viscous liquid dosage forms; consultancy and research pertaining to pharmacology in the nature of alternative drugs for the young, elderly and those with difficulties swallowing pills and tablets; development of in vitro and in vivo preclinical tests of drug candidates and potential drugs; biochemical and molecular biological analyses; scientific, industrial, technological and biotechnological analysis in the field of pharmaceutical and veterinary drug and medicine analysis, analysis of drug delivery apparatus and containers, analysis of synthetic peptides for pharmaceutical purposes, analysis of peptide substrates, analysis for the purpose of detecting various toxins, analysis of drug candidates and potential drugs
Case File Event Statements
  • 7/31/2019 - 5 years ago
    70 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 5/3/2019 - 6 years ago
    69 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 10/2/2017 - 7 years ago
    68 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 9/14/2016 - 8 years ago
    67 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 9/14/2016 - 8 years ago
    66 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/2/2012 - 12 years ago
    65 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/29/2012 - 12 years ago
    64 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B
  • 8/15/2012 - 12 years ago
    63 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 8/15/2012 - 12 years ago
    62 - TEAS DELETE 1(B) BASIS RECEIVED Type: D1BR
  • 2/22/2012 - 13 years ago
    61 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/21/2012 - 13 years ago
    60 - EXTENSION 5 GRANTED Type: EX5G
  • 2/10/2012 - 13 years ago
    59 - EXTENSION 5 FILED Type: EXT5
  • 2/10/2012 - 13 years ago
    58 - TEAS EXTENSION RECEIVED Type: EEXT
  • 8/23/2011 - 13 years ago
    57 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/20/2011 - 13 years ago
    56 - EXTENSION 4 GRANTED Type: EX4G
  • 8/17/2011 - 13 years ago
    55 - EXTENSION 4 FILED Type: EXT4
  • 8/17/2011 - 13 years ago
    54 - TEAS EXTENSION RECEIVED Type: EEXT
  • 2/26/2011 - 14 years ago
    53 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/25/2011 - 14 years ago
    52 - EXTENSION 3 GRANTED Type: EX3G
  • 2/23/2011 - 14 years ago
    51 - EXTENSION 3 FILED Type: EXT3
  • 2/23/2011 - 14 years ago
    50 - TEAS EXTENSION RECEIVED Type: EEXT
  • 10/13/2010 - 14 years ago
    49 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 9/9/2010 - 14 years ago
    48 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 9/8/2010 - 14 years ago
    47 - EXTENSION 2 GRANTED Type: EX2G
  • 8/23/2010 - 14 years ago
    46 - EXTENSION 2 FILED Type: EXT2
  • 8/23/2010 - 14 years ago
    45 - TEAS EXTENSION RECEIVED Type: EEXT
  • 1/30/2010 - 15 years ago
    44 - EXTENSION 1 GRANTED Type: EX1G
  • 12/21/2009 - 15 years ago
    43 - EXTENSION 1 FILED Type: EXT1
  • 1/29/2010 - 15 years ago
    42 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 12/21/2009 - 15 years ago
    41 - TEAS EXTENSION RECEIVED Type: EEXT
  • 8/25/2009 - 15 years ago
    40 - NOA MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/2/2009 - 16 years ago
    39 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/13/2009 - 16 years ago
    38 - NOTICE OF PUBLICATION Type: NPUB
  • 4/28/2009 - 16 years ago
    37 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 4/27/2009 - 16 years ago
    36 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/4/2009 - 16 years ago
    35 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/4/2009 - 16 years ago
    34 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/1/2009 - 16 years ago
    33 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/8/2008 - 16 years ago
    32 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/8/2008 - 16 years ago
    31 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/8/2008 - 16 years ago
    30 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/12/2008 - 16 years ago
    29 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/12/2008 - 16 years ago
    28 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/11/2008 - 16 years ago
    27 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/11/2008 - 16 years ago
    26 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/11/2008 - 17 years ago
    25 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/11/2008 - 17 years ago
    24 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/11/2008 - 17 years ago
    23 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/6/2008 - 17 years ago
    22 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/5/2008 - 17 years ago
    21 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/5/2008 - 17 years ago
    20 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 11/26/2007 - 17 years ago
    19 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 11/26/2007 - 17 years ago
    18 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 11/26/2007 - 17 years ago
    17 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 11/6/2007 - 17 years ago
    16 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK
  • 5/4/2007 - 18 years ago
    15 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 5/4/2007 - 18 years ago
    14 - ASSIGNED TO LIE Type: ALIE
  • 10/25/2006 - 18 years ago
    13 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 10/25/2006 - 18 years ago
    12 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 10/3/2006 - 18 years ago
    11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/3/2006 - 18 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/2/2006 - 18 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/2/2006 - 18 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/30/2006 - 19 years ago
    7 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/30/2006 - 19 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/16/2006 - 19 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/27/2006 - 19 years ago
    4 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/15/2006 - 19 years ago
    3 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/15/2006 - 19 years ago
    2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 9/9/2005 - 19 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP